Literature DB >> 23064547

Regulated specific proteolysis of the Cajal body marker protein coilin.

Venkatramreddy Velma1, Hanna J Broome, Michael D Hebert.   

Abstract

Cajal bodies (CB) are subnuclear domains that contain various proteins with diverse functions including the CB marker protein coilin. In this study, we investigate the proteolytic activity of calpain on coilin. Here, we report a 28-kDa cleaved coilin fragment detected by two coilin antibodies that is cell cycle regulated, with levels that are consistently reduced during mitosis. We further show that an in vitro calpain assay with full-length or C-terminal coilin recombinant protein releases the same size cleaved fragment. Furthermore, addition of exogenous RNA to purified coilin induces proteolysis by calpain. We also report that the relative levels of this cleaved coilin fragment are susceptible to changes induced by various cell stressors, and that coilin localization is affected by inhibition or knockdown of calpain both under normal and stressed conditions. Collectively, our data suggest that coilin is subjected to regulated specific proteolysis by calpain, and this processing may play a role in the regulation of coilin activity and CB formation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23064547      PMCID: PMC3519941          DOI: 10.1007/s00412-012-0387-4

Source DB:  PubMed          Journal:  Chromosoma        ISSN: 0009-5915            Impact factor:   4.316


  47 in total

1.  Nucleation of nuclear bodies by RNA.

Authors:  Sergey P Shevtsov; Miroslav Dundr
Journal:  Nat Cell Biol       Date:  2011-01-16       Impact factor: 28.824

2.  Dynamic control of Cajal body number during zebrafish embryogenesis.

Authors:  Magdalena Strzelecka; Andrew C Oates; Karla M Neugebauer
Journal:  Nucleus       Date:  2010 Jan-Feb       Impact factor: 4.197

3.  Inhibition of protein dephosphorylation results in the accumulation of splicing snRNPs and coiled bodies within the nucleolus.

Authors:  C E Lyon; K Bohmann; J Sleeman; A I Lamond
Journal:  Exp Cell Res       Date:  1997-01-10       Impact factor: 3.905

4.  Phosphorylation regulates the activity of the SMN complex during assembly of spliceosomal U snRNPs.

Authors:  Matthias Grimmler; Liane Bauer; Marjaana Nousiainen; Roman Körner; Gunter Meister; Utz Fischer
Journal:  EMBO Rep       Date:  2005-01       Impact factor: 8.807

Review 5.  Calpain: new perspectives in molecular diversity and physiological-pathological involvement.

Authors:  T C Saido; H Sorimachi; K Suzuki
Journal:  FASEB J       Date:  1994-08       Impact factor: 5.191

6.  The putative nuclear receptor mediator TIF1alpha is tightly associated with euchromatin.

Authors:  E Remboutsika; Y Lutz; A Gansmuller; J L Vonesch; R Losson; P Chambon
Journal:  J Cell Sci       Date:  1999-06       Impact factor: 5.285

7.  Molecular determinants of survival motor neuron (SMN) protein cleavage by the calcium-activated protease, calpain.

Authors:  Jennifer L Fuentes; Molly S Strayer; A Gregory Matera
Journal:  PLoS One       Date:  2010-12-30       Impact factor: 3.240

8.  Coilin phosphomutants disrupt Cajal body formation, reduce cell proliferation and produce a distinct coilin degradation product.

Authors:  Zunamys I Carrero; Venkatramreddy Velma; Heather E Douglas; Michael D Hebert
Journal:  PLoS One       Date:  2011-10-03       Impact factor: 3.240

9.  In vitro RNase and nucleic acid binding activities implicate coilin in U snRNA processing.

Authors:  Hanna J Broome; Michael D Hebert
Journal:  PLoS One       Date:  2012-04-27       Impact factor: 3.240

10.  Microinjection of anti-coilin antibodies affects the structure of coiled bodies.

Authors:  F Almeida; R Saffrich; W Ansorge; M Carmo-Fonseca
Journal:  J Cell Biol       Date:  1998-08-24       Impact factor: 10.539

View more
  9 in total

1.  Identification of processing elements and interactors implicate SMN, coilin and the pseudogene-encoded coilp1 in telomerase and box C/D scaRNP biogenesis.

Authors:  Aaron R Poole; Isioma I Enwerem; Ian A Vicino; Jackson B Coole; Stanley V Smith; Michael D Hebert
Journal:  RNA Biol       Date:  2016-07-15       Impact factor: 4.652

2.  Nucleocytoplasmic transport of intrinsically disordered proteins studied by high-speed super-resolution microscopy.

Authors:  Samuel L Junod; Joseph M Kelich; Jiong Ma; Weidong Yang
Journal:  Protein Sci       Date:  2020-03-03       Impact factor: 6.725

3.  Cajal body proteins differentially affect the processing of box C/D scaRNPs.

Authors:  Isioma I Enwerem; Guowei Wu; Yi Tao Yu; Michael D Hebert
Journal:  PLoS One       Date:  2015-04-13       Impact factor: 3.240

Review 4.  Asparaginase treatment side-effects may be due to genes with homopolymeric Asn codons (Review-Hypothesis).

Authors:  Julian Banerji
Journal:  Int J Mol Med       Date:  2015-07-15       Impact factor: 4.101

5.  Coilin association with Box C/D scaRNA suggests a direct role for the Cajal body marker protein in scaRNP biogenesis.

Authors:  Isioma I Enwerem; Venkatramreddy Velma; Hanna J Broome; Marija Kuna; Rowshan A Begum; Michael D Hebert
Journal:  Biol Open       Date:  2014-04-15       Impact factor: 2.422

6.  Nuclear Fragile X Mental Retardation Protein is localized to Cajal bodies.

Authors:  Alain Y Dury; Rachid El Fatimy; Sandra Tremblay; Timothy M Rose; Jocelyn Côté; Paul De Koninck; Edouard W Khandjian
Journal:  PLoS Genet       Date:  2013-10-31       Impact factor: 5.917

7.  Nuclear protein IK undergoes dynamic subcellular translocation and forms unique nuclear bodies during the cell cycle.

Authors:  Liyan Hu; Feikun Yang; Xianan Liu; Dazhong Xu; Wei Dai
Journal:  Biomark Res       Date:  2013-02-18

8.  Altered dynamics of scaRNA2 and scaRNA9 in response to stress correlates with disrupted nuclear organization.

Authors:  Madelyn K Logan; Marilyn F Burke; Michael D Hebert
Journal:  Biol Open       Date:  2018-09-27       Impact factor: 2.422

9.  SMN and coilin negatively regulate dyskerin association with telomerase RNA.

Authors:  Aaron R Poole; Michael D Hebert
Journal:  Biol Open       Date:  2016-06-15       Impact factor: 2.422

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.